We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

MRI IV Pump System Features Integrated SET SpO2 and Dose Error Reduction System

By MedImaging International staff writers
Posted on 11 Jun 2012
Print article
Image: The MRidium MRI infusion pump (Photo courtesy of IRadimed).
Image: The MRidium MRI infusion pump (Photo courtesy of IRadimed).
New magnetic resonance imaging (MRI) pump systems are the only nonmagnetic intravenous (IV) pumps designed specifically for use in the MRI setting.

Safety in the MR is the primary concern when it comes to meeting needs for required patient care. These risks are well known: equipment can fly into the MR, cause artifacts on the images of the scan, or just shut down during crucial deliveries of medications and monitoring.

Novation (Irving, TX, USA), the largest healthcare supply contracting company in the United States, has awarded IRadimed Corp. (Wintern Park, FL, USA), a three-year single source contract for its MRidium MRI infusion pump systems. Effective September 1, 2012, the agreement makes the MRidium systems available to all 65,000 VHA (Irving, TX, USA), United Healthcare (UHC; Minnetonka, MN, USA), and Provista (Irving, TX, USA) members served by Novation. MRidium was awarded the contract under Novation’s MR- compatible IV pump category. This new agreement offers a broad base of new customers for IRadimed to partner with and grow its current strong base of MRidium MRI infusion pumps in the US market.

“It is critical to have products which have been designed with the utmost care and thorough insight of this harsh and potentially dangerous environment,” said Roger Susi, president and founder of IRadimed.

The MRidium 3860 MRI infusion system also incorporates Masimo’s (Irvine, CA, USA) SET SpO2 system for continuous monitoring of patients from the intensive care unit (ICU), neonatal intensive care unit (NICU), neurology, and other areas of the hospital right into the MRI suite. The 3860 system also offers an expanded drug library with DERS (dose error reduction system), which helps prevent medication entry errors while programming infusions, and provides the patient safety features that are quickly becoming the standard in infusion therapy in general patient care areas.

The MRidium system also supports infusion delivery in the MR through additional accessories associated with the MRI infusion pump. The system offers a modular second channel, which when attached to the 3860 pump, allows for delivery of two medications simultaneously during patient scans. An optional fully featured wireless remote control monitor is also available that has true plug and play capabilities, requiring no installation. A full range of available infusion sets are also available to provide the clinical flexibility needed in the demanding MRI environment.

IRadimed is a developer of MRI-safe products and infusion therapy. The company’s founder is the pioneering developer of both the world’s first and best selling MRI compatible monitoring system and the only nonmagnetic IV pumps designed specifically for use in the MRI environment.

Related Links:
Novation
IRadimed

Computed Tomography System
Aquilion ONE / INSIGHT Edition
Digital X-Ray Detector Panel
Acuity G4
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Portable Color Doppler Ultrasound System
S5000

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more